Interpace Diagnostics Group Stock Forecast
A very red day for Interpace Diagnostics Group stock price after a -8.34% fall in the Thursday trading session
(Updated on Apr 25, 2024)
The Interpace Diagnostics Group stock price fell by -8.34% on the last day (Thursday, 25th Apr 2024) from $1.55 to $1.42. During the last trading day the stock fluctuated 0.704% from a day low at $1.42 to a day high of $1.43. The price has risen in 4 of the last 10 days and is up by 5.37% over the past 2 weeks. Volume has increased on the last day by 2 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 thousand shares were bought and sold for approximately $3.38 thousand.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.42 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 45.29% during the next 3 months and, with a 90% probability hold a price between $2.07 and $3.03 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
IDXG Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Interpace Diagnostics Group stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.47 and $1.53. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -18.71%. Further fall is indicated until a new bottom pivot has been found. Interpace Diagnostics Group gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Interpace Diagnostics Group stock
On the downside, the stock finds support just below today's level from accumulated volume at $1.35 and $1.20. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Interpace Diagnostics Group finds support just below today's level at $1.35. If this is broken, then the next support from accumulated volume will be at $1.20 and $1.09.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0100 between high and low, or 0.704%. For the last week, the stock has had daily average volatility of 2.03%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (IDXG) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Interpace Diagnostics Group to open at $1.42, and during the day (based on 14 day Average True Range), to move between $1.31 and $1.53, which gives a possible trading interval of +/-$0.112 (+/-7.86%) up or down from last closing price. If Interpace Diagnostics Group takes out the full calculated possible swing range there will be an estimated 15.72% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.45 (1.93%) than the support at $1.35 (5.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Interpace Diagnostics Group stock A Buy?
The Interpace Diagnostics Group stock holds several negative signals and despite the positive trend, we believe Interpace Diagnostics Group will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -3.813 Sell Candidate Downgraded
Predicted Opening Price for Interpace Diagnostics Group of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $1.42 ( 0.117%) | $1.42 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for IDXG
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.43 | 0.82 % | |
| R2 | 1.43 | 0.552 % | ||
| R1 | 1.43 | 0.386 % | ||
| Current price: | 1.42 | |||
| Support | S1 | 1.42 | -0.151 % | |
| S2 | 1.42 | -0.317 % | ||
| S3 | 1.41 | -0.586 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.66 | 16.70 % | |
| R2 | 1.63 | 14.59 % | ||
| R1 | 1.45 | 1.93 % | ||
| Current price | 1.42 | |||
| Support | S1 | 1.35 | -5.10% | |
| S2 | 1.20 | -15.64% | ||
| S3 | 1.09 | -23.66% |
FAQ
Click here for our free guide on how to buy Interpace Diagnostics Group Stock.
